// App-Quantinova.ai

4692 : Thalidomide (THAL) and Lenalidomide (LEN)-Associated Venous Thromboembolism (VTE): Optimal Prophylaxis Strategies Remain Elusive

Researchers

Presenter

  • Dustin B Liebling

Principal Investigators

  • Alfred W. Rademaker

  • Dennis P. West

  • Bing Bing Weitner

  • Beatrice J. Edwards

  • Steven M. Belknap

  • Andrew Thurston

  • Monica Boen

  • Katrina-Marie E Tulas

  • Judith M McKoy-Bent

  • Jowella Pineda

Medical Centers

  • Northwestern University, Feinberg School of Medicine, Chicago, IL

  • Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Multiple Myeloma

Biomarkers

  • TIMP Metallopeptidase Inhibitor 1

Drug/Treatment

  • Lenalidomide

  • Thalidomide

  • Warfarin

  • Aspirin

  • Albyl-E

  • Enoxaparin sodium

  • Heparin

Outcome

  • N/A

Study Design

  • randomized

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved